Lumibird SA (LBIRD) AI Stock Analysis

• Market Cap: €481.55M
• Dividend Yield: N/A
• Average Volume (3M): 32.82K
• Price to Earnings (P/E): 34.0
• Beta (1Y): 0.55
• Revenue Growth: 5.66%
• EPS Growth: 66.79%
• Country: FR
• Employees: 1,027
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Diagnostics & Research
• EPS (TTM): 0.40
• Shares Outstanding: 22,466,883
• 10 Day Avg. Volume: 22,637
• 30 Day Avg. Volume: 32,817
• PEG Ratio: 0.25
• Price to Book (P/B): 2.31
• Price to Sales (P/S): 2.11
• P/FCF Ratio: 68.05
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 1.02
• Revenue Forecast (FY): €252.65M

• Rating: 54 Neutral
• Price Target: €22.00 ▲(3.29% Upside)
• Action: Downgraded Date: 03/13/26
• Date: Action: Downgraded 03/13/26

The score is driven primarily by a solid-but-not-strong financial profile: improved profitability and manageable leverage are tempered by volatile free cash flow and modest cash conversion. Technicals add caution with the stock trading below key moving averages and weak momentum. Valuation further caps the score due to a relatively high P/E and no dividend support.

Positive Factors

Diversified end-markets & strategic partnerships

Lumibird's exposure across defense, medical and industrial end markets and explicit strategic partnerships provide durable demand channels and access to large contracts. This diversification and partner-backed access reduce single-market cyclicality and support repeatable revenue streams.

Negative Factors

Volatile free cash flow and weak cash conversion

Inconsistent operating and free cash flow — with prior negative FCF years and only ~30% conversion in 2025 — suggests working-capital swings or capex intensity. This reduces resilience, constrains reinvestment or debt reduction, and limits the durability of reported profits.

Lumibird SA Business Overview & Revenue Model

Company Description

Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two divisions, Photonics and Medical. The Photonics division offers solid-state lasers, high power laser...

Read more

Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two divisions, Photonics and Medical. The Photonics division offers solid-state lasers, high power laser...

How the Company Makes Money

Lumibird generates revenue primarily through the sale of its laser systems and components to various industries. The company has established key revenue streams from both product sales and ongoing service contracts for maintenance and support. Add...

Read more

Lumibird generates revenue primarily through the sale of its laser systems and components to various industries. The company has established key revenue streams from both product sales and ongoing service contracts for maintenance and support. Add...

Lumibird SA Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	225.60M	210.06M	206.55M	194.29M	162.47M
Gross Profit	0.00	16.06M	128.11M	15.36M	18.49M
EBITDA	25.70M	31.03M	27.31M	32.09M	31.81M
Net Income	14.00M	5.70M	7.13M	11.35M	13.86M
Balance Sheet
Total Assets	428.90M	429.80M	405.25M	372.04M	347.62M
Cash, Cash Equivalents and Short-Term Investments	61.60M	71.14M	56.20M	61.68M	97.13M
Total Debt	146.20M	161.06M	145.08M	114.18M	112.03M
Total Liabilities	222.60M	231.79M	211.95M	178.61M	166.29M
Stockholders Equity	206.30M	198.01M	193.30M	193.44M	181.33M
Cash Flow
Free Cash Flow	7.00M	11.41M	-4.89M	-28.02M	6.47M
Operating Cash Flow	23.10M	34.37M	20.67M	1.43M	26.57M
Investing Cash Flow	-15.90M	-22.84M	-46.15M	-29.34M	-28.63M
Financing Cash Flow	-10.70M	3.39M	21.69M	-7.89M	18.20M

Lumibird SA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 21.30
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LBIRD, the sentiment is Positive. The current price of 21.3 is below the 20-day moving average (MA) of 21.74, below the 50-day MA of 22.48, and above the 200-day MA of 20.43, indicating a neutral trend. The MACD of -0.42 indicates Positive momentum. The RSI at 49.37 is Neutral, neither overbought nor oversold. The STOCH value of 66.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:LBIRD.

Lumibird SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BIM	68 Neutral	€11.06B	32.73	9.69%	0.82%	8.28%	-8.08%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
LBIRD	54 Neutral	€481.55M	34.02	5.51%	―	5.66%	66.79%
DIM	52 Neutral	€16.46B	76.93	6.65%	0.31%	7.72%	53.84%
ALMDT	47 Neutral	€171.19M	-0.80	59.08%	―	6.75%	15.48%
ALMKT	46 Neutral	€36.73M	-0.39	―	―	-0.80%	24.14%
ALTHE	46 Neutral	€27.44M	-1.41	467.60%	―	-4.70%	-64.31%